CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Virbac

Bertrand Havrileck, Head of Corporate Pharma R&D, Virbac and Arnaud Steiner, R&D Packaging Manager

Packaging, A Key Element In Improving Animal Health

Bertrand Havrileck

Bertrand Havrileck

Packaging for veterinary medicinal products has much in common with packaging for human medicinal products, particularly because they are under comparable regulatory requirements. However, packaging used in the veterinary pharmaceutical industry requires reflection and adaptations specific to the sector. In animal health, our target is more complex since we must adapt to the end-users who will be administering the medicine as well as to the animal who will be receiving the medicinal products. Therefore, the same product will not be offered in the same size and the same container to farmers breeding herds of foodproducing animals as it would be for people treating their companion animals.


In any case, regardless of the target; the products must always be effective, practical, and safe for both the endusers and the animals.


Packaging: A Clear Added Value


Since 2005 at Virbac, we have fully integrated packaging in the research and development programs of our new products. Packaging is at first designed to preserve what it is containing. Thus, it will protect the composition from elements that may affect its action, such as light, oxidation and water, or it may preserve certain key attributes, such as formula palatable agents, so important to treatment compliance in dogs and cats.


However, for Virbac, packaging is much more than just a container. It is planned and designed with three key dimensions in mind: content effectiveness, safe product use, and helps to the administration for better compliance.


Working on these three dimensions that look contradictory complicates the development of the packaging. At Virbac, we strive to make this complexity less noticeable to the user, drawing on very precise ergonomics, classification, and observing the customer experience during testing.


 


 


Adding value to packaging is a natural response to Virbac’s values, which are committed to animal health and welfare. In fact, we have been recognized four times at the PharmaPack awards, particularly for the Smart Cap, a very advanced technical cap for dispensing liquid products. After five years of research and development, we found the optimal combination between the ergonomics and protection needed to ensure safe use by the end-users and their bystanders.


Packaging R&D Must be Adapted to Societal Changes


 Packaging must meet regulatory requirements as well as new demands from various targets including those from the Society itself. Using medicines, particularly in the area of animal health, must be simple, safe, and able to adapt to any need.


Society is evolving and what we know about it is as well. This is why we consider as a must that environmental issues should be included in R&D programs. At Virbac, we are actively looking to offer eco-design packaging solutions with innovative processes that use recyclable biomaterials or eco-refills that reduce waste volume as well.


In our line of business, it is essential to keep an open mind and look to new technologies to meet future packaging challenges. 3D printing, for example, is nowadays a tool that is used to test and create innovations in a more rapid, eco-friendly and economical manner: reducing the time needed to create a prototype from several months to a few hours while significantly reducing waste generated during development.


To conclude, Virbac’s credo is to develop solutions that meet quality, safety and ergonomic criteria, to facilitate handling and convenience for the end-users, to adapt to the animal to be treated and to conditions in the field


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/leadership-perspective/packaging-a-key-element-in-improving-animal-health-nwid-382.html